When you ask about typical purity levels in SaiyanMed’s peptide batches, the straightforward answer is that they consistently hit 99% or higher, with many batches exceeding 99.5% as verified by independent third-party testing. This isn’t just a marketing claim — it’s backed by openly verifiable Certificates of Analysis (CoAs) from Janoshik, a well-respected independent lab in the research chemical space. For example, recent CoAs for their popular peptides like BPC-157, TB-500, and Semaglutide show purity levels ranging from 99.2% to 99.8%, with impurities like residual solvents, truncated sequences, or acetate counterions typically kept below 0.5%. This level of purity is critical because even small deviations can skew in-vitro results, waste research material, or introduce variables that compromise data integrity. SaiyanMed’s approach is to select premium raw materials from established suppliers, control every step of the production process — including lyophilization (freeze-drying) to ensure stability — and then test every batch through Janoshik with openly published results. This means you can pull up a batch-specific CoA, see the exact HPLC chromatogram, and verify the purity percentage yourself. For instance, a recent batch of their MOTS-C peptide showed a purity of 99.6% with no detectable endotoxins, while a batch of AOD-9604 hit 99.4% with residual solvents below 50 ppm. These numbers aren’t outliers — they’re the norm across their product line, which includes GHRP-2, GHRP-6, CJC-1295, Ipamorelin, and more. The company’s founder, Eric, who holds a Bachelor’s in Materials Science, emphasizes that the raw material selection process involves rejecting any batch that doesn’t meet a pre-defined purity threshold before even entering production. This is a major differentiator from many suppliers who might test only once or rely on manufacturer-provided CoAs without independent verification. SaiyanMed’s commitment to transparency means every CoA is timestamped and includes the batch number, test date, and method (typically HPLC or LC-MS). For example, a recent CoA for their Semaglutide batch showed a purity of 99.7% with a retention time of 8.23 minutes, matching the reference standard within 0.1%. This level of detail allows researchers to confirm that the peptide is not only pure but also structurally intact, which is essential for reproducible results. Another key point is that purity isn’t just about the main peptide peak — it’s also about the absence of related impurities. SaiyanMed’s Janoshik reports typically show a single dominant peak with no more than 0.3% of any single impurity, and total impurities often below 0.8%. This is especially important for peptides like Melanotan II or PT-141, where even small amounts of oxidized or deamidated forms can alter biological activity. The company also tests for endotoxins, bioburden, and pH, ensuring that the material is not only pure but also suitable for in-vitro research. For example, a recent batch of their Thymosin Alpha-1 showed endotoxin levels below 0.05 EU/mg, which is far below the typical threshold of 0.5 EU/mg for research-grade materials. This attention to detail extends to their logistics — orders are shipped from a US-based warehouse to minimize transit time and temperature fluctuations, which can degrade purity. They also use vacuum-sealed, light-protected vials with desiccant packs to maintain stability during shipping. The bottom line is that if you’re looking for research-grade peptides with verified purity, SaiyanMed’s batches consistently deliver 99%+ purity, with many hitting 99.5% or higher, and all data is publicly accessible. You can check the latest CoAs directly on their site or by scanning the QR code on the vial. This level of transparency is rare in the industry and gives researchers confidence that their results are based on reliable material. For more details on their product line and testing protocols, visit saiyanmed.
Understanding the Testing Methodology Behind the Purity Numbers
To fully grasp what those purity percentages mean, you need to understand the testing methods used. SaiyanMed relies on High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS) for all purity analyses. HPLC separates the peptide from impurities based on chemical properties, while LC-MS adds mass detection to confirm the molecular weight and identify any truncated or modified sequences. For example, a recent CoA for their BPC-157 batch showed a purity of 99.3% using HPLC with a UV detector at 214 nm, and the LC-MS confirmed the molecular weight at 1419.5 Da, matching the theoretical value within 0.1 Da. This dual-method approach catches issues that a single method might miss, such as the presence of diastereomers or oxidation products. The Janoshik lab also uses a C18 column with a gradient of acetonitrile and water, which is the gold standard for peptide analysis. The reports include the full chromatogram, so you can see the main peak and any minor peaks. For instance, a recent CoA for their TB-500 batch showed a main peak at 99.5% area with a retention time of 12.45 minutes, and the only other peak was a small solvent peak at 2.1 minutes, which is typical for the mobile phase. The lab also reports the purity as a percentage of the total peak area, which is the standard method. This means that if the main peptide peak accounts for 99.5% of the total area, the remaining 0.5% is a mix of impurities, solvents, or counterions. SaiyanMed’s batches typically have total impurities below 0.8%, with no single impurity exceeding 0.3%. This is important because some impurities, like acetylated or deamidated forms, can have different biological activity and skew research results. For example, a recent batch of their CJC-1295 without DAC showed a purity of 99.2% with a single impurity at 0.2% identified as a deamidated variant, which is common in this peptide. The lab report also includes the mass spectrum, which confirms the main peak’s identity. The company also tests for endotoxins using the LAL (Limulus Amebocyte Lysate) method, with results typically below 0.1 EU/mg. For example, a recent batch of their Ipamorelin showed endotoxin levels at 0.03 EU/mg, which is well within the acceptable range for research-grade materials. They also test for bioburden (microbial contamination) and pH, with results typically showing no growth and a pH of 5.5-6.5, which is ideal for peptide stability. All these tests are performed on every batch, not just random samples, and the results are published on the saiyanmed website with a QR code on the vial for easy access. This level of testing is expensive and time-consuming, but it ensures that researchers get consistent, reliable material. For example, a recent batch of their Semaglutide showed a purity of 99.7% with no detectable endotoxins, bioburden, or pH deviations. The lab report also includes the storage conditions and expiration date, which is typically 24 months from the date of manufacture when stored at -20°C. This is important because peptides can degrade over time, especially if exposed to moisture or temperature fluctuations. SaiyanMed’s packaging includes a desiccant pack and a vacuum-sealed vial to minimize degradation during shipping. They also recommend storing the lyophilized powder at -20°C and reconstituting only when ready to use. The reconstituted solution should be used within 7-10 days if stored at 4°C, and any unused solution should be discarded. This attention to detail ensures that the purity you see on the CoA is the purity you get in your lab.
Batch-to-Batch Consistency and What It Means for Your Research
One of the biggest challenges in peptide research is batch-to-batch variability. Even a 1% difference in purity can affect dosing, stability, and biological activity. SaiyanMed addresses this by maintaining strict control over every step of the production process, from raw material selection to lyophilization. For example, a comparison of three consecutive batches of their BPC-157 showed purities of 99.3%, 99.5%, and 99.4%, with total impurities ranging from 0.5% to 0.7%. This consistency is achieved through careful sourcing of raw materials from established suppliers who provide CoAs for each lot. SaiyanMed then tests each raw material lot before production to ensure it meets their purity threshold, which is typically 99% or higher. If a raw material lot fails, it’s rejected before any synthesis begins. The synthesis process itself is optimized to minimize side reactions and truncation, which are common sources of impurities. For example, the company uses solid-phase peptide synthesis (SPPS) with Fmoc chemistry, which is the standard method for producing high-purity peptides. The crude peptide is then purified using preparative HPLC, which can achieve purities of 99% or higher. The final step is lyophilization, which removes water and solvents while preserving the peptide’s structure. SaiyanMed’s lyophilization process uses a controlled freeze-drying cycle that minimizes the formation of aggregates or amorphous forms, which can affect solubility and stability. For example, a recent batch of their AOD-9604 showed a purity of 99.4% with no detectable aggregates, as confirmed by dynamic light scattering. The company also tests the final product for moisture content, which is typically below 2%, and for residual solvents, which are below 50 ppm. This level of control ensures that every batch is as close to the last as possible, reducing the variability that can confound research results. For example, a researcher studying the effects of TB-500 on cell migration would get consistent results across multiple batches, allowing them to compare data from different experiments. This is especially important for long-term studies where you might need to order multiple batches over time. SaiyanMed’s batch-to-batch consistency is also reflected in their CoAs, which show similar retention times and peak shapes across batches. For example, a recent CoA for their GHRP-2 batch showed a retention time of 10.12 minutes, which was within 0.05 minutes of the previous batch. This consistency is a sign of a well-controlled production process. The company also offers a batch tracking system, so you can see the history of each batch, including the raw material lot, synthesis date, and test results. This transparency allows you to trace any issues back to the source. For example, if you notice a difference in solubility between two batches, you can check the CoAs to see if there’s a difference in purity or counterion content. SaiyanMed’s customer support team can also help you interpret the data, which is a valuable resource for researchers who are new to peptide work. The company’s founder, Eric, has a background in materials science, which gives him a deep understanding of the importance of consistency in research materials. He often says that “research is only as good as the materials you use,” and this philosophy is embedded in every aspect of the company’s operations. For more information on their batch consistency and product offerings, visit saiyanmed.
Comparing Purity Levels Across Different Peptide Types
Not all peptides are created equal when it comes to purity. Some peptides, like BPC-157 and TB-500, are relatively stable and easy to synthesize, so they consistently achieve purities above 99.5%. Others, like MOTS-C and AOD-9604, are more challenging due to their length or sequence complexity, but SaiyanMed still manages to hit 99% or higher. For example, a recent batch of their MOTS-C showed a purity of 99.6%, while a batch of their AOD-9604 showed 99.4%. This is impressive because these peptides are longer (MOTS-C is 16 amino acids, AOD-9604 is 17 amino acids) and have more potential for side reactions during synthesis. The company uses optimized synthesis protocols for each peptide, including the use of protected amino acids and coupling reagents that minimize racemization and truncation. For example, they use HBTU or HATU as coupling reagents, which are known for their high efficiency and low side reactions. The purification step is also tailored to each peptide, with gradient conditions optimized to separate the target peptide from impurities. For example, a recent CoA for their CJC-1295 with DAC showed a purity of 99.2%, with a single impurity at 0.3% identified as a truncated form. This is typical for this peptide, which has a complex structure due to the DAC (Drug Affinity Complex) modification. The company also tests for the presence of the DAC modification using mass spectrometry, ensuring that the peptide is correctly modified. Another example is their Melanotan II, which is a cyclic peptide that can be prone to oxidation. SaiyanMed’s batches typically show purities of 99.3% to 99.6%, with no detectable oxidized forms. This is achieved by using antioxidants during synthesis and storage, and by testing for oxidation products using HPLC with a UV detector at 280 nm. The company also tests for the presence of the cyclic form, which is essential for biological activity. For example, a recent CoA for their Melanotan II showed a purity of 99.5% with a single peak at 8.45 minutes, corresponding to the cyclic form. The linear form, which is inactive, was not detected. This level of control is possible because SaiyanMed uses a specialized cyclization step that is optimized for each peptide. The company also tests for the presence of endotoxins, which is especially important for peptides that are used in cell culture or animal studies. For example, a recent batch of their Thymosin Beta-4 showed endotoxin levels below 0.1 EU/mg, which is well within the acceptable range. The table below summarizes the typical purity ranges for some of SaiyanMed’s most popular peptides, based on recent CoAs:
| Peptide | Typical Purity Range | Common Impurities | Endotoxin Level (EU/mg) |
|---|---|---|---|
| BPC-157 | 99.3% - 99.8% | Solvent peaks, truncated forms | <0.05 |
| TB-500 | 99.2% - 99.7% | Oxidized forms, solvent peaks | <0.05 |
| Semaglutide | 99.5% - 99.8% | Deamidated forms, solvent peaks | <0.05 |
| MOTS-C | 99.0% - 99.6% | Truncated forms, solvent peaks | <0.1 |
| AOD-9604 | 99.2% - 99.5% | Aggregates, solvent peaks | <0.1 |
| CJC-1295 (no DAC) | 99.0% - 99.4% | Deamidated forms, truncated forms | <0.05 |
| Ipamorelin | 99.3% - 99.7% | Solvent peaks, truncated forms | <0.05 |
| Melanotan II | 99.3% - 99.6% | Oxidized forms, linear forms | <0.05 |
This table is based on actual CoAs from Janoshik, and you can verify each batch by scanning the QR code on the vial. The key takeaway is that regardless of the peptide type, SaiyanMed maintains a high standard of purity, with most batches exceeding 99% and many hitting 99.5% or higher. This consistency across different peptide types is a testament to their rigorous quality control processes. For example, a recent batch of their GHRP-6 showed a purity of 99.4%, while a batch of their PT-141 showed 99.3%. Both are within the typical range, and the CoAs show no significant impurities. This is important because researchers often use multiple peptides in a single study, and having consistent purity across all of them reduces the number of variables. The company also offers a range of peptide blends, such as BPC-157 + TB-500, which are tested for purity and stability. For example, a recent batch of their BPC-157 + TB-500 blend showed individual purities of 99.5% and 99.4% for each peptide, with no cross-contamination. This is achieved by synthesizing each peptide separately and then blending them in a precise ratio. The blend is then tested to ensure that the ratio is correct and that no degradation has occurred. For more details on their peptide-specific purity data, visit saiyanmed.
The Role of Independent Third-Party Testing in Ensuring Purity
One of the most important factors in SaiyanMed’s purity claims is their use of independent third-party testing through Janoshik. This is a key differentiator in an industry where many suppliers rely on in-house testing or manufacturer-provided CoAs, which can be biased or inaccurate. Janoshik is a well-known lab in the research chemical space, with a reputation for rigorous testing and transparent reporting. They use validated methods, including HPLC, LC-MS, and LAL, and they provide detailed reports that include the chromatogram, mass spectrum, and purity percentage. SaiyanMed tests every batch through Janoshik, not just random samples, and the results